Intestinal permeability and its relevance for absorption and elimination

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · see citing works

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

Juliano, R. L., & Ling, V. W. T. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,317 · see citing works

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Thiebaut, F., TSURUO, T., Hamada, H., Gottesman, M. M., PASTAN, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777 · see citing works

Colonic Health: Fermentation and Short Chain Fatty Acids

Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739 · see citing works

Drug Metabolism and Disposition

(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,518 · see citing works

Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs

Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824 · see citing works

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401 · see citing works

Role of P-Glycoprotein in Pharmacokinetics

Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 1,002 · see citing works

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

Greiner, B., Eichelbaum, M. F., Fritz, P., Kreichgauer, H. P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917 · see citing works

Overview of gut flora and probiotics

Holzapfel, W. H., Haberer, P., Snel, J., Schillinger, U., & Veld, J. H. J. H. I. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00044-0 · Cited by 887 · see citing works

Multiple molecular mechanisms for multidrug resistance transporters

Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 863 · see citing works

Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797 · cited 1× · see citing works

Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism

Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 790 · see citing works

Active outward transport of daunomycin in resistant ehrlich ascites tumor cells

Danø, K. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90191-0 · Cited by 729 · see citing works

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

Lown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin‐Ren, P., Brown, M. B., Guo, W.-S., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 679 · see citing works

Molecular and Integrative Physiology of Intestinal Peptide Transport

Daniel, H. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.144149 · Cited by 602 · see citing works

OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine

Cvetković, M., Leake, B. F., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 592 · see citing works

Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

Hilgendorf, C., Ahlin, G., Seithel‐Keuth, A., Artursson, P., Ungell, A.-L. B., & Karlsson, J. E. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583 · see citing works

Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling

Sm, H., Temple, R. C., Throckmorton, D. C., & Lesko, L. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100054 · Cited by 580 · see citing works

The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity

Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004) · Current Drug Delivery · doi:10.2174/1567201043480036 · Cited by 559 · see citing works

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

Rostami‐Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 533 · see citing works

Mass transport Phenomena and Models: Theoretical Concepts

Flynn, G. L., Yalkowsky, S. H., & Roseman, T. J. (1974) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600630403 · Cited by 515 · see citing works

Human Intestinal Permeability

Lennernäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970332a · Cited by 498 · see citing works

The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology

Kottra, G., & Daniel, H. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1101-4 · Cited by 472 · see citing works

Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918

Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., Huinink, W. W. T. B., Schot, M. E., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 465 · see citing works

Correlation of Human Jejunal Permeability (in Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach

Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 458 · see citing works

Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs

Sun, D., Lennernäs, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D. R., Fleisher, D., Lee, K., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 448 · see citing works

Comparison Between Permeability Coefficients in Rat and Human Jejunum

Fagerholm, U., Johansson, M., & Lennernäs, H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016065715308 · Cited by 438 · see citing works

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*

Gorski, J. C., Jones, D. R., HAEHNERDANIELS, B., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 409 · see citing works

Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans

Glaeser, H., Bailey, D. G., Dresser, G. K., Gregor, J. C., Schwarz, U. I., McGrath, J., Jolicoeur, E., Lee, W., Leake, B. F., Tirona, R. G., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100056 · Cited by 406 · see citing works

The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons.

Lande, M. B., Donovan, J. M., & Zeidel, M. L. (1995) · The Journal of General Physiology · doi:10.1085/jgp.106.1.67 · Cited by 393 · see citing works

Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model

Cao, X., Gibbs, S. T., Fang, L., Miller, H. A., Landowski, C. P., Shin, H., Lennernäs, H., Zhong, Y., Amidon, G. L., Yu, L. X., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9041-2 · Cited by 387 · see citing works

Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells

Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368 · see citing works

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

Wu, C.-Y., Benet, L. Z., Hébert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., & Wacher, V. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90168-x · Cited by 356 · see citing works

Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus

Christians, U., Jacobsen, W., Benet, L. Z., & Lampen, A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00003 · Cited by 324 · see citing works

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

Thummel, K. E. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00039-2 · Cited by 318 · see citing works

Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development

Bergstr�m, M., Grahn�n, A., & L�ngstr�m, B. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0643-x · Cited by 311 · see citing works

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

Lin, J. H. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00171-0 · Cited by 310 · see citing works

5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter

Han, H.-K., de Vrueh, R. L. A., Rhie, J. K., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919319810 · Cited by 298 · see citing works

Introduction to intestinal microecology

Luckey, T. D. (1972) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/25.12.1292 · Cited by 288 · see citing works

Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules

Peltier, S., Oger, J.-M., Lagarce, F., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274 · see citing works

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*

Floren, L. C., Bekersky, I., Benet, L. Z., Mekki, Q. A., Dressler, D. E., Lee, J. W., Roberts, J. P., & Hébert, M. F. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90150-8 · Cited by 269 · see citing works

Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat

Ungell, A. ‐., Nylander, S., Bergstrand, S., et al. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970218s · Cited by 258 · see citing works

Measurements of Intestinal Permeability Using Low Molecular Weight Polyethylene Glycols (PEG 400)

CHADWICK, V. S., Phillips, S. F., & Hofmann, A. F. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)32197-3 · Cited by 251 · see citing works

The drug efflux–metabolism alliance: biochemical aspects

Benet, L. Z., & Cummins, C. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00178-8 · Cited by 227 · see citing works

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting

Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224 · see citing works

Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds

Dressman, J., Amidon, G. L., & Fleisher, D. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740523 · Cited by 223 · see citing works

Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation

Fricker, G., Drewe, J., Huwyler, J., Gutmann, H., & Beglinger, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15612.x · Cited by 223 · see citing works

Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models

Lennernäs, H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06084.x · Cited by 222 · see citing works

ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO

Petri, N., Tannergren, C., Holst, B., Mellon, F. A., Bao, Y., Plumb, G. W., Bacon, J., O’Leary, K. A., Kroon, P. A., Knutson, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.805 · Cited by 220 · see citing works

Regional Rectal Perfusion: A New in Vivo Approach to Study Rectal Drug Absorption in Man

Lennernäs, H., Fagerholm, U., Raab, Y., Gerdin, B., & Hällgren, R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016216905197 · Cited by 219 · see citing works

Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation

Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059689 · Cited by 217 · see citing works

The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension

Lennernäs, H., & Abrahamsson, B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055263 · Cited by 216 · see citing works

Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

Makhey, V. D., Guo, A., Norris, D. A., Hu, P., Yan, J., & Sinko, P. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011971303880 · Cited by 215 · see citing works

Gene and Protein Expression of P-Glycoprotein, MRP1, MRP2, and CYP3A4 in the Small and Large Human Intestine

Berggren, S., Gall, C. M., Wollnitz, N., et al. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0600687 · Cited by 211 · see citing works

Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man

Lennernäs, H., Ahrenstedt, Ö., Hällgren, R., et al. (1992) · Pharmaceutical Research · doi:10.1023/a:1015888813741 · Cited by 203 · see citing works

Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells

Seithel‐Keuth, A., Karlsson, J., Hilgendorf, C., Björquist, A., & Ungell, A.-L. B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.03.003 · Cited by 201 · see citing works

Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract

Thörn, M., Finnström, N., Lundgren, S., Rane, A., & Lööf, L. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02389.x · Cited by 197 · see citing works

Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400.

CHADWICK, V. S., Phillips, S. F., & Hofmann, A. F. (1977) · PubMed · Cited by 190 · see citing works

Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein

Karlsson, J. E., Kuo, S., Ziemniak, J. A., et al. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13914.x · Cited by 180 · see citing works

Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach

Sinko, P. J., Leesman, G. D., & Amidon, G. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015892621261 · Cited by 178 · see citing works

Species Differences in Size Discrimination in the Paracellular Pathway Reflected by Oral Bioavailability of Poly(ethylene glycol) and d-Peptides

He, Y., Murby, S., Warhurst, G., et al. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970120d · Cited by 178 · see citing works

Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans

Lennernäs, H., Nylander, S., & Ungell, A. ‐. (1997) · Pharmaceutical Research · doi:10.1023/a:1012121632357 · Cited by 173 · see citing works

The pivotal role of hepatocytes in drug discovery

Soars, M. G., McGinnity, D. F., Grime, K., & Riley, R. J. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.11.002 · Cited by 172 · see citing works

Clinical Relevance of P-Glycoprotein in Drug Therapy

Lin, J. H., & Yamazaki, M. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026871 · Cited by 167 · see citing works

SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers

Ieiri, I., Suwannakul, S., Maeda, K., Uchimaru, H., Hashimoto, K., Kimura, M., Fujino, H., Hirano, M., Kusuhara, H., Irie, S., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100190 · Cited by 164 · see citing works

In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model

Cummins, C. L., Salphati, L., Reid, M. J., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044719 · Cited by 161 · see citing works

Pharmacokinetics and metabolism in early drug discovery

Smith, D. A., & Waterbeemd, H. V. D. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80056-8 · Cited by 160 · see citing works

P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans

Drescher, S., Glaeser, H., Mürdter, T. E., et al. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.27 · Cited by 159 · see citing works

Efflux transporters in ulcerative colitis

Englund, G., Jacobson, A., Rorsman, F., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20030 · Cited by 156 · see citing works

Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans

Read, N. W., Al-Janabi, M., Bates, T. E., & Barber, D. C. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90382-7 · Cited by 152 · see citing works

Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia

Stephens, R. H., O’Neill, C. A., Warhurst, A., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38782-8 · Cited by 149 · see citing works

The Use of BDDCS in Classifying the Permeability of Marketed Drugs

Benet, L. Z., Amidon, G. L., Barends, D. M., et al. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9523-x · Cited by 147 · see citing works

Modulation of oral bioavailability of anticancer drugs: from mouse to man

Schellens, J. H. M., Malingré, M. M., Kruijtzer, C. M. F., Bardelmeijer, H. A., van Tellingen, O., Schinkel, A. H., & Beijnen, J. H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00153-6 · Cited by 147 · see citing works

Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo

Soars, M. G., Grime, K., Sproston, J. L., Webborn, P. J. H., & Riley, R. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014464 · Cited by 144 · see citing works

Intestinal Microflora: Metabolism of Drugs and Carcinogens

Goldin, B. R. (1990) · Annals of Medicine · doi:10.3109/07853899009147240 · Cited by 143 · see citing works

Measurements of Intestinal Permeability Using Low Molecular Weight Polyethylene Glycols (PEG 400)

CHADWICK, V. S., Phillips, S. F., & Hofmann, A. F. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)32196-1 · Cited by 142 · see citing works

Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats

Tamura, S., Ohike, A., Ibuki, R., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10041 · Cited by 140 · see citing works

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism*1

TANNERGREN, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.012 · Cited by 138 · see citing works

Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity

Leslie, E. M., Watkins, P. B., Kim, R. B., & Brouwer, K. L. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119073 · Cited by 137 · see citing works

Modulation of the Permeability of H2 Receptor Antagonists Cimetidine and Ranitidine by P-Glycoprotein in Rat Intestine and the Human Colonic Cell Line Caco-2

Collett, A., Higgs, N. B., Sims, E. J., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37939-x · Cited by 136 · see citing works

Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas

Nakamura, T., Sakaeda, T., Ohmoto, N., Tamura, T., Aoyama, N., Shirakawa, T., Kamigaki, T., Nakamura, T., Kim, K. I., Kim, S. R., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.1.4 · Cited by 136 · see citing works

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Bardelmeijer, H. A., Ouwehand, M., Buckle, T., et al. (2002) · PubMed · Cited by 135 · see citing works

Intestinal Drug Transporters: In Vivo Function and Clinical Importance

Kunta, J. R., & Sinko, P. J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489144 · Cited by 134 · see citing works

Transport Characteristics of Fexofenadine in the Caco-2 Cell Model

Petri, N., Tannergren, C., Rungstad, D., & Lennernäs, H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036913.90332.b1 · Cited by 130 · see citing works

Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol

Schwarz, U. I., Hanso, H., Oertel, R., Miehlke, S., Kuhlisch, E., Glaeser, H., Hitzl, M., Dresser, G. K., Kim, R. B., & Kirch, W. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100191 · Cited by 129 · see citing works

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

Russell, T., Stoltz, M., & Weir, S. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90052-2 · Cited by 127 · see citing works

Development of a new engineering-based capsule for human drug absorption studies

Wilding, I. R., Hirst, P. H., & Connor, A. L. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00311-4 · Cited by 122 · see citing works

Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

Borgström, L., Nyberg, L., Jonsson, S., Lindberg, C., & Paulson, J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05334.x · Cited by 121 · see citing works

The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

Lennernäs, H., Nilsson, D., Sm, A., et al. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05691.x · Cited by 117 · see citing works

In Vitro–In Vivo Correlation of Hepatobiliary Drug Clearance in Humans

Ghibellini, G., Vasist, L., Leslie, E. M., Heizer, W. D., Kowalsky, R. J., Calvo, B. F., & Brouwer, K. L. R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100059 · Cited by 115 · see citing works

A New Principle for Tight Junction Modulation Based on Occludin Peptides

Tavelin, S., Hashimoto, K., Malkinson, J. P., Lazorova, L., Tóth, I., & Artursson, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1530 · Cited by 113 · see citing works

Gastric Emptying: Comparison of Scintigraphic, Polyethylene Glycol Dilution, and Paracetamol Tracer Assessment Techniques

Näslund, E. B. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023930 · Cited by 111 · see citing works

Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability

Winiwarter, S., Ax, F., Lennernäs, H., et al. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(02)00163-8 · Cited by 111 · see citing works

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

Hochman, J. H., Yamazaki, M., Ohe, T., et al. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337559 · Cited by 110 · see citing works

Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview

Kruijtzer, C. M. F., Beijnen, J. H., & Schellens, J. H. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-516 · Cited by 110 · see citing works

Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)

Bourdet, D. L., Pritchard, J. B., & Thakker, D. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091223 · Cited by 109 · see citing works

Interactions of Human P-glycoprotein with Simvastatin, Simvastatin Acid, and Atorvastatin

Hochman, J. H., Pudvah, N. T., Qiu, J., Yamazaki, M., Tang, C., Lin, J. H., & Prueksaritanont, T. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041466.84653.8c · Cited by 109 · see citing works

Kinetic Considerations for the Quantitative Assessment of Efflux Activity and Inhibition: Implications for Understanding and Predicting the Effects of Efflux Inhibition

Kalvass, J. C., & Pollack, G. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9135-x · Cited by 108 · see citing works

Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation?

Lennernäs, H. (1995) · Pharmaceutical Research · doi:10.1023/a:1016220428705 · Cited by 106 · see citing works

Human Jejunal Permeability of Cyclosporin A: Influence of Surfactants on P-Glycoprotein Efflux in Caco-2 Cells

Chiu, Y.-Y., Higaki, K., Neudeck, B. L., Barnett, J. L., Welage, L. S., & Amidon, G. L. (2003) · Pharmaceutical Research · doi:10.1023/a:1023481418576 · Cited by 105 · see citing works

Mechanism of Absorption Enhancement in Humans After Rectal Administration of Ampicillin in Suppositories Containing Sodium Caprate

Lindmark, T., Söderholm, J. D., Olaison, G., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012112219578 · Cited by 105 · see citing works

A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans

Chiou, W. L., Chung, S. M., Wu, T. C., et al. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39093 · Cited by 105 · see citing works

Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat.

Lennernäs, H., Ahrenstedt, Ö., & Ungell, A. ‐. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04309.x · Cited by 101 · see citing works

Jejunal Absorption and Metabolism of R/S-Verapamil in Humans

Sandström, R., Karlsson, A. L., Knutson, L., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011916329863 · Cited by 100 · see citing works

Innovative Methods to Study Human Intestinal Drug Metabolism in Vitro: Precision-Cut Slices Compared with Ussing Chamber Preparations

van de Kerkhof, E. G., Ungell, A.-L. B., Sjöberg, Å. K., de Jager, M. H., Hilgendorf, C., de Graaf, I. A. M., & Groothuis, G. M. M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011148 · Cited by 100 · see citing works

The Method of Intraluminal Perfusion of the Human Small Intestine

Modigliani, R., Rambaud, J. C., & Bernier, J. J. (2009) · Digestion · doi:10.1159/000197443 · Cited by 99 · see citing works

Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(−/−) Mouse Intestine

Stephens, R. H., Tanianis-Hughes, J., Higgs, N. B., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041236 · Cited by 98 · see citing works

Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil*

Gramatté, T., & Oertel, R. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70031-7 · Cited by 97 · see citing works

Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilities

Johnson, D. A., & Amidon, G. L. (1988) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(88)80123-1 · Cited by 93 · see citing works

Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms

Fagerholm, U., Lindahl, A. H., & Lennernäs, H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06093.x · Cited by 93 · see citing works

Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique

von Richter, O., Greiner, B., Fromm, M. F., FRASER, R., Omari, T. I., Barclay, M. L., Dent, J., Somogyi, A. A., & Eichelbaum, M. F. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117937 · Cited by 91 · see citing works

Bioavailability and pharmacokinetics of cimetidine

Grahnén, A., von Bahr, C., Lindström, B., et al. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00605632 · Cited by 90 · see citing works

Controlled release technologies for drug delivery

Brayden, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02874-5 · Cited by 89 · see citing works

Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine,

Tannergren, C. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00238-8 · Cited by 89 · see citing works

Taxol transport by human intestinal epithelial Caco-2 cells.

Walle, U. K., & Walle, T. (1998) · PubMed · Cited by 87 · see citing works

Jejunal permeability in humans invivo and rats insitu: investigation of molecular size selectivity and solvent drag

FAGERHOLM, NILSSON, Knutson, & LENNERNÄS (1999) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1999.00510.x · Cited by 85 · see citing works

Differential absorption of amoxicillin from the human small and large intestine

Barr, W. H., Zola, E. M., Candler, E. L., Hwang, S.-M., Tendolkar, A. V., Shamburek, R. D., Parker, B., & Hilty, M. D. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.138 · Cited by 82 · see citing works

The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique

Lennernäs, H., Knutson, L., Knutson, T. W., Hussain, A., Lesko, L. J., Salmonson, T., & Amidon, G. L. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00005-2 · Cited by 80 · see citing works

CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies

Engman, H., Lennernäs, H., Taipalensuu, J., et al. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1123 · Cited by 80 · see citing works

Discussion

Waterbeemd, H. V. D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00051-7 · Cited by 78 · see citing works

The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)‐verapamil in humans

Sandström, R., Knutson, T. W., Knutson, L., Jansson, B., & Lennernäs, H. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00999.x · Cited by 77 · see citing works

Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparation

Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059690 · Cited by 77 · see citing works

Jejunal permeability and hepatic extraction of fluvastatin in humans

Lindahl, A. H., Sandström, R., Ungell, A.-L. B., Abrahamsson, B., Knutson, T. W., Knutson, L., & Lennernäs, H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90145-9 · Cited by 77 · see citing works

The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique

Tannergren, C., Knutson, T. W., Knutson, L., & Lennernäs, H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01722.x · Cited by 74 · see citing works

Variable expression of CYP and Pgp genes in the human small intestine

Lindell, M., Karlsson, M. O., Lennernäs, H., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01154.x · Cited by 74 · see citing works

Increased??Absorption??of??Digoxin from??the??Human??Jejunum Due??to??Inhibition??of??Intestinal Transporter-Mediated Efflux

Igel, S., Drescher, S., rdter, T. E. M., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746090-00005 · Cited by 74 · see citing works

Interactions in the renal and biliary elimination of digoxin: Stereoselective difference between quinine and quinidine

Hedman, A., Angelin, B., Arvidsson, A., Dahlqvist, R., & Nilsson, B. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.3 · Cited by 74 · see citing works

Digoxin-verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans

Hedman, A., Angelin, B., Arvidsson, A., et al. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.26 · Cited by 70 · see citing works

Site-dependent small intestinal absorption of ranitidine

Gramatté, T., Desoky, E. E., & Klotz, U. E. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192558 · Cited by 69 · see citing works

Pharmacokinetics of gefitinib in humans: The influence of gastrointestinal factors

Bergman, E., Forsell, P., Persson, E. M., Knutson, L., Dickinson, P. A., Smith, R. P., Swaisland, H., Farmer, M. R., Cantarini, M., & Lennernäs, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.002 · Cited by 69 · see citing works

Molecular and Pharmacokinetic Properties of 222 Commercially Available Oral Drugs in Humans.

Sakaeda, T., Okamura, N., Nagata, S., Yagami, T., Horinouchi, M., Okumura, K., Yamashita, F., & Hashida, M. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.935 · Cited by 66 · see citing works

Dependence of intestinal absorption in vivo on the unstirred layer

Winne, D. (1978) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495554 · Cited by 65 · see citing works

Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine

Takamatsu, N., Kim, O., Welage, L. S., Idkaidek, N., Hayashi, Y., Barnett, J. L., YAMAMOTO, R., Lipka, E., Lennernäs, H., Hussain, A. S., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011020025338 · Cited by 64 · see citing works

Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression*

Pinto, A. G., Wang, Y.-H., Chalasani, N., et al. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.002 · Cited by 64 · see citing works

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut

Bardelmeijer, H. A., Ouwehand, M., Malingré, M. M., et al. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0394-2 · Cited by 63 · see citing works

Nonlinearity of amoxicillin absorption kinetics in human

Paintaud, G., Alván, G., Dahl, M., Grahnén, A., Sjövall, J., & Svensson, J. O. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333024 · Cited by 63 · see citing works

Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase

Bergman, E., Forsell, P., Åberg, A. T., Persson, E. M., Hedeland, M., Bondesson, U., Knutson, L., & Lennernäs, H. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.015 · Cited by 61 · see citing works

Quinidine reduces biliary clearance of digoxin in man

Angelin, B., Arvidsson, A., Dahlqvist, R., et al. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01246.x · Cited by 61 · see citing works

Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion

Takamatsu, N., Welage, L. S., Idkaidek, N., Liu, D.-Y., Lee, P. I.-D., Hayashi, Y., Rhie, J. K., Lennernäs, H., Barnett, J. L., Shah, V. P., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012134219095 · Cited by 60 · see citing works

Intestinal Absorptive Transport of the Hydrophilic Cation Ranitidine: A Kinetic Modeling Approach to Elucidate the Role of Uptake and Efflux Transporters and Paracellular vs. Transcellular Transport in Caco-2 Cells

Bourdet, D. L., Pollack, G. M., & Thakker, D. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0204-y · Cited by 58 · see citing works

The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine

Tamura, S., Tokunaga, Y., Ibuki, R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050716 · Cited by 57 · see citing works

Oral Absorption of Peptides: Influence of pH and Inhibitors on the Intestinal Hydrolysis of Leu-Enkephalin and Analogues

Friedman, D. I., & Amidon, G. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015842609565 · Cited by 55 · see citing works

Presentation of a Structurally Diverse and Commercially Available Drug Data Set for Correlation and Benchmarking Studies

Sköld, C., Winiwarter, S., Wernevik, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0506219 · Cited by 55 · see citing works

The Absence of Stereoselective P-Glycoprotein-mediated Transport ofR/S-Verapamil Across the Rat Jejunum

Sandström, R., Karlsson, A. L., & Lennernäs, H. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb07133.x · Cited by 55 · see citing works

Pharmacokinetics of felodipine in patients with liver disease

Reg�rdh, C. G., Edgar, B., Olsson, R., Kendall, M. J., Collste, P., & Shansky, C. W. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558072 · Cited by 54 · see citing works

Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig

Amelsberg, A., Schteingart, C. D., Ton-Nu, H.-T., & Af, H. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8612999 · Cited by 51 · see citing works

Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) mice

Stephens, R. H., O’Neill, C. A., Bennett, J., Humphrey, M., Henry, B., Rowland, M., & Warhurst, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704668 · Cited by 51 · see citing works

The Lack of Effect of Induced Net Fluid Absorption on thein vivoPermeability of Terbutaline in the Human Jejunum

Fagerholm, U., Borgström, L., Ahrenstedt, Ö., et al. (1995) · Journal of drug targeting · doi:10.3109/10611869509015945 · Cited by 48 · see citing works

Comparison of Furosemide and Vinblastine Secretion from Cell Lines Overexpressing Multidrug Resistance Protein (P-Glycoprotein) and Multidrug Resistance-Associated Proteins (MRP1 and MRP2)

Flanagan, S. D., Cummins, C. L., Susanto, M., et al. (2002) · Pharmacology · doi:10.1159/000056161 · Cited by 46 · see citing works

Paracetamol absorption from different sites in the human small intestine.

Gramatté, T., & Richter, K. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04312.x · Cited by 44 · see citing works

The permeability coefficient of the wall of a villous membrane

Winne, D. (1978) · Journal of Mathematical Biology · doi:10.1007/bf02478521 · Cited by 44 · see citing works

Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect

Enokizono, J., Kusuhara, H., & Sugiyama, Y. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012567 · Cited by 44 · see citing works

A Residence-Time Distribution Analysis of the Hydrodynamics within the Intestine in Man during a Regional Single-pass Perfusion with Loc-I-Gut: In-vivo Permeability Estimation

Lennernäs, H., Lee, I.-D., Fagerholm, U., et al. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06092.x · Cited by 44 · see citing works

Showdown at the tight junction

Soergel, K. H. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90974-h · Cited by 43 · see citing works

Regional Intestinal Absorption and Biliary Excretion of Fluvastatin in the Rat: Possible Involvement of mrp2

Lindahl, A. H., Sjöberg, Å. K., Bredberg, U., Toreson, H., Ungell, A.-L. B., & Lennernäs, H. (2004) · Molecular Pharmaceutics · doi:10.1021/mp0499297 · Cited by 42 · see citing works

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs

Han, H.-K., Rhie, J. K., Oh, D.-M., Saito, G., Hsu, C.-P., Stewart, B. H., & Amidon, G. L. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980132e · Cited by 42 · see citing works

FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL

Petri, N., Bergman, E., Forsell, P., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008409 · Cited by 42 · see citing works

Comparison of P-glycoprotein-mediated drug–digoxin interactions in Caco-2 with human and rodent intestine: Relevance to in vivo prediction

Collett, A., Tanianis-Hughes, J., Carlson, G., Harwood, M. D., & Warhurst, G. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.013 · Cited by 41 · see citing works

Optimising drug development: strategies to assess drug metabolism/transporter interaction potential — towards a consensus

Tucker, G., Houston, J. B., & Huang, S. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00148-8 · Cited by 41 · see citing works

Contributions of Saturable Active Secretion, Passive Transcellular, and Paracellular Diffusion to the Overall Transport of Furosemide Across Adenocarcinoma (Caco-2) Cells

Flanagan, S. D., Takahashi, L. H., Liu, X., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10099 · Cited by 39 · see citing works

The Influence of Net Water Absorption on the Permeability of Antipyrine and Levodopa in the Human Jejunum

Nilsson, D., Fagerholm, U., & Lennernäs, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018941200575 · Cited by 39 · see citing works

The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans

Lennernäs, H., Gjellan, K., Hällgren, R., et al. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778772 · Cited by 39 · see citing works

Saturable Absorptive Transport of the Hydrophilic Organic Cation Ranitidine in Caco-2 Cells: Role of pH-Dependent Organic Cation Uptake System and P-Glycoprotein

Bourdet, D. L., & Thakker, D. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0251-4 · Cited by 39 · see citing works

The Biopharmaceutic Drug Classification and Drugs Administered in Extended Release (Er) Formulations

Corrigan, O. I. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6036-0_9 · Cited by 38 · see citing works

Influence of Morphometric Factors on Quantitation of Paracellular Permeability of Intestinal Epithelia In Vitro

Collett, A., Walker, D. W., Sims, E. J., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012154506858 · Cited by 38 · see citing works

Griseofulvin absorption from different sites in the human small intestine

Gramatté, T. (1994) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510150903 · Cited by 38 · see citing works

Delivery aspects of small peptides and substrates for peptide transporters

Steffansen, B., Nielsen, C. U., & Frøkjær, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.004 · Cited by 37 · see citing works

The influence of gastrointestinal transit on drug absorption in healthy volunteers.

Riley, S., Sutcliffe, F., Kim, M., Kapás, M., Rowland, M., & Turnberg, L. A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04104.x · Cited by 35 · see citing works

HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154

Takada, T., Weiss, H. M., Kretz, O., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000497 · Cited by 33 · see citing works

Rat Jejunal Permeability and Metabolism of μ-Selective Tetrapeptides in Gastrointestinal Fluids from Humans and Rats

Krondahl, E., Orzechowski, A., Ekström, G., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012144232666 · Cited by 32 · see citing works

A Perfusion Bioreactor for Intestinal Tissue Engineering

Kim, S. S., Penkala, R. A., & Abrahimi, P. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.039 · Cited by 31 · see citing works

Transporter-mediated Intestinal Absorption of Fexofenadine in Rats

Kikuchi, A., Nozawa, T., Wakasawa, T., et al. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.308 · Cited by 31 · see citing works

Repeated Oral Rifampicin Decreases the Jejunal Permeability of R/S-Verapamil in Rats

Sandström, R., & Lennernäs, H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11829-6 · Cited by 31 · see citing works

Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers

Petri, N., Borga, O., Nyberg, L., et al. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44071 · Cited by 30 · see citing works

Folate absorption from folate-fortified and processed foods using a human ileostomy model

Witthöft, C. M., Arkbåge, K., Johansson, M., et al. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051620 · Cited by 30 · see citing works

Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine

Berggren, S., Lennernäs, P., Ekelund, M., et al. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021495 · Cited by 29 · see citing works

Systemic Availability of the Active Metabolite Hydroxy‐Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract

Hinderling, P. H., Karara, A. H., Tao, B., et al. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006293767 · Cited by 28 · see citing works

Intestinal drug absorption and bioavailability: beyond involvement of single transport function

Lennernäs, H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702973 · Cited by 28 · see citing works

Enantiomeric separation of verapamil and norverapamil using Chiral-AGP® as the stationary phase

Sandström, R., Lennernäs, H., Öhlén, K., et al. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(99)00093-x · Cited by 27 · see citing works

Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance

Hedman, A., Angelin, B., Arvidsson, A., et al. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314854 · Cited by 26 · see citing works

A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from 13 phase I studies

Nyberg, L., Månsson, W., Abrahamsson, B., et al. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.01.005 · Cited by 25 · see citing works

Effects of a non‐absorbable osmotic load on drug absorption in healthy volunteers.

Riley, S., Kim, M., Sutcliffe, F., et al. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04105.x · Cited by 24 · see citing works

Dose-dependent absorption of amoxicillin in patients with an ileostomy

Sjövall, J., Alván, G., Åkerlund, J. E., et al. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333023 · Cited by 23 · see citing works

The Method of Intraluminal Perfusion of the Human Small Intestine

Modigliani, R., Rambaud, J. C., & Bernier, J. J. (2009) · Digestion · doi:10.1159/000197453 · Cited by 23 · see citing works

Permeability and clearance views of drug absorption: A commentary

Lennernäs, H., Crison, J. R., & Amidon, G. L. (1995) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02354289 · Cited by 22 · see citing works

Contribution of the intestine to the first-pass metabolism of felodipine in the rat.

Wang, S. X., Sutfin, T. A., Bäärnhielm, C., & Regårdh, C. G. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22256-x · Cited by 21 · see citing works

Absorption Profiles for Polyethylene Glycols After Regional Jejunal Perfusion and Oral Load in Healthy Humans

Söderholm, J. D., Olaison, G., Kald, A., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018836803254 · Cited by 18 · see citing works

Inhibition by basic drugs of digoxin secretion into human bile

Hedman, A. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280136 · Cited by 18 · see citing works

Clinical pharmacology and therapy

(2018) · Clinical pharmacology and therapy · doi:10.32756/0869-5490 · Cited by 15 · see citing works

Investigations of the In-vitro Metabolism of Three Opioid Tetrapeptides by Pancreatic and Intestinal Enzymes

Krondahl, E., von Euler-Chelpin, H., Orzechowski, A., et al. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774642 · Cited by 13 · see citing works

Stereoselective Inhibition by the Diastereomers Quinidine and Quinine of Uptake of Cardiac Glycosides into Isolated Rat Hepatocytes

Hedman, A., & Meijer, D. K. F. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970334v · Cited by 13 · see citing works

The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides

Hedman, A., & Meijer, D. K. F. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80011-4 · Cited by 12 · see citing works

Intestinal Absorption of Amiodarone in Man

Pfeiffer, A., Vidon, N., Bovet, M., et al. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01864.x · Cited by 10 · see citing works

Cimetidine bioavailability and variable renal clearance

Grahn�n, A. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00556904 · Cited by 10 · see citing works

No effect of probenecid on the renal and biliary clearances of digoxin in man.

Hedman, A., Angelin, B., Arvidsson, A., et al. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05614.x · Cited by 9 · see citing works

EUFEPS conference on Drug Transporters at Copenhagen: Integrative approaches in ADME research

Meijer, D. K. F., & Lennernäs, H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.001 · Cited by 7 · see citing works

The Method of Intraluminal Perfusion of the Human Small Intestine

Rambaud, J. C., Modigliani, R., & Bernier, J. J. (2009) · Digestion · doi:10.1159/000197460 · Cited by 6 · see citing works

Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow

Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734 · see citing works

Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies

Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702 · see citing works

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model

Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12134 · Cited by 425 · see citing works

Autism spectrum disorders and intestinal microbiota

De Angelis, M., Francavilla, R., Piccolo, M., De Giacomo, A., & Gobbetti, M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1035855 · Cited by 311 · see citing works

Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study

Johannsson, G., Bergthorsdottir, R., Nilsson, A. G., Lennernas, H., Hedner, T., & Skrtic, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0170 · Cited by 173 · see citing works

In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim

Sjögren, E., Westergren, J., Grant, I., Hanisch, G., Lindfors, L., Lennernäs, H., Abrahamsson, B., & Tannergren, C. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.019 · Cited by 168 · see citing works

Gastrointestinal malabsorption of thyroxine

Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00168 · Cited by 164 · see citing works

Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders: A Systematic Review

Marí-Bauset, S., Zazpe, I., Mari-Sanchis, A., Llopis-González, A., & Morales-Suárez-Varela, M. (2014) · Journal of Child Neurology · doi:10.1177/0883073814531330 · Cited by 136 · see citing works

Regional intestinal drug permeation: Biopharmaceutics and drug development

Lennernäs, H. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.025 · Cited by 103 · see citing works

The BCS, BDDCS, and Regulatory Guidances

Chen, M.-L., Amidon, G. L., Benet, L. Z., Lennernas, H., & Yu, L. X. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0438-1 · Cited by 93 · see citing works

Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates – An evaluation and case study using GastroPlus™

Heikkinen, A. T., Baneyx, G., Caruso, A., & Parrott, N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.013 · Cited by 76 · see citing works

Tumor suppressor scribble regulates assembly of tight junctions in the intestinal epithelium

Ivanov, A. I., Young, C., Beste, K. D., Capaldo, C. T., Humbert, P. O., Brennwald, P., Parkos, C. A., & Nusrat, A. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090220 · Cited by 73 · see citing works

Levothyroxine: conventional and novel drug delivery formulations.

Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac030 · Cited by 63 · see citing works

Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy

Amidon, K. S., Langguth, P., Lennernäs, H., Yu, L., & Amidon, G. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.109 · Cited by 44 · see citing works

Quantitation of small intestinal permeability during normal human drug absorption

Levitt, D. G. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-34 · Cited by 32 · see citing works

Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments

Johannsson, G., Skrtic, S., Lennernäs, H., Quinkler, M., & Stewart, P. M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.925865 · Cited by 21 · see citing works

In Vitro to in Vivo Extrapolation and Physiologically Based Modeling of Cytochrome P450 Mediated Metabolism in Beagle Dog Gut Wall and Liver

Heikkinen, A. T., Fowler, S., Gray, L., Li, J., Peng, Y., Yadava, P., Railkar, A., & Parrott, N. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300692k · Cited by 20 · see citing works

Early ADME/T Predictions: Toy or Tool?

Tetko, I. V., & Oprea, T. I. (2008) · Chemoinformatics Approaches to Virtual Screening · doi:10.1039/9781847558879-00240 · Cited by 5 · see citing works

Interaction between transcellular and paracellular water transport pathways through Aquaporin 5 and the tight junction complex

Kawedia, J. D., Nieman, M. L., Boivin, G. P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608384104 · Cited by 135 · see citing works

Water channels and barriers formed by claudins

Rosenthal, R., Günzel, D., Theune, D., Czichos, C., Schulzke, J., & Fromm, M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13383 · Cited by 76 · see citing works

Two-Path Impedance Spectroscopy for Measuring Paracellular and Transcellular Epithelial Resistance

Krug, S. M., Fromm, M., & Günzel, D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.003 · Cited by 106 · see citing works

NaPi-mediated Transcellular Permeation is the Dominant Route in Intestinal Inorganic Phosphate Absorption in Rats

Eto, N., Tomita, M., & Hayashi, M. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.217 · Cited by 46 · see citing works

Paracellular transport as a strategy for energy conservation by multicellular organisms?

Yu, A. S. L. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1301852 · Cited by 19 · see citing works